Artificial intelligence for precision medicine in autoimmune liver disease

This review outlines the evidence on how AI and machine learning can address unmet needs in autoimmune liver diseases. In PSC, MRCP+ metrics can significantly improve the current diagnostic approach and risk prediction. In AIH, LiverMultiScan’s cT1 is described as an accurate non-invasive biomarker for risk stratification and monitoring, enabling precision-medicine workflows.